NovaBridge Biosciences American Depositary Shares
NBP
39 hedge funds and large institutions have $22.7M invested in NovaBridge Biosciences American Depositary Shares in 2024 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 11 closing their positions.
214% more call options, than puts
Call options by funds: $22K | Put options by funds: $7K
22% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 9
0.17% more ownership
Funds ownership: 14.94% → 15.11% (+0.17%)
3% less capital invested
Capital invested by funds: $23.5M → $22.7M (-$768K)
11% less funds holding
Funds holding: 44 → 39 (-5)
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CP
Caligan Partners
New York
|
+$1.39M |
| 2 |
BFM
Boothbay Fund Management
New York
|
+$697K |
| 3 |
EAM
Exome Asset Management
New York
|
+$600K |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$131K |
| 5 |
Invesco
Atlanta,
Georgia
|
+$120K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$934K |
| 2 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$596K |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
-$590K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$295K |
| 5 |
Barclays
London,
United Kingdom
|
-$248K |
NBP Hedge Fund Activity: Q1 2024 in Review
39 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in NovaBridge Biosciences American Depositary Shares (NBP) for Q1 2024, worth a combined $22.7M — down 3.3% from $23.5M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of NBP and 6 opened new positions — a net loss of 5 holders — while 9 trimmed existing stakes and 11 added.
The largest buyer was Caligan Partners, opening a new position worth an estimated $1.39M. The largest seller was Morgan Stanley, cutting an estimated $934K.
- 39 institutional investors held NovaBridge Biosciences American Depositary Shares (NBP) as of Q1 2024, down from 44 in Q4 2023.
- Funds reported $22.7M of NovaBridge Biosciences American Depositary Shares stock for Q1 2024, down 3.3% quarter-over-quarter.
- 6 funds opened new NovaBridge Biosciences American Depositary Shares positions in Q1 2024 and 11 closed out, a net change of -5 holders.
- The largest NovaBridge Biosciences American Depositary Shares buyer in Q1 2024 was Caligan Partners, an estimated $1.39M added.
- The largest NovaBridge Biosciences American Depositary Shares seller in Q1 2024 was Morgan Stanley, an estimated $934K sold.
Based on aggregated 13F filings for Q1 2024.